OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Long-term results of liver resection for hepatocellular carcinoma in noncirrhotic liver
Wladimir Faber, Siamak Sharafi, Martin Stockmann, et al.
Surgery (2012) Vol. 153, Iss. 4, pp. 510-517
Open Access | Times Cited: 61
Wladimir Faber, Siamak Sharafi, Martin Stockmann, et al.
Surgery (2012) Vol. 153, Iss. 4, pp. 510-517
Open Access | Times Cited: 61
Showing 26-50 of 61 citing articles:
Treatment strategies for locally advanced hepatocellular carcinoma
Eduardo de Souza Martins Fernandes, Pablo Duarte Rodrigues, Mário Reis Álvares‐da‐Silva, et al.
Translational Gastroenterology and Hepatology (2019) Vol. 4, pp. 12-12
Open Access | Times Cited: 19
Eduardo de Souza Martins Fernandes, Pablo Duarte Rodrigues, Mário Reis Álvares‐da‐Silva, et al.
Translational Gastroenterology and Hepatology (2019) Vol. 4, pp. 12-12
Open Access | Times Cited: 19
Diagnostic value of the γ-glutamyltransferase and alanine transaminase ratio, alpha-fetoprotein, and protein induced by vitamin K absence or antagonist II in hepatitis B virus-related hepatocellular carcinoma
Guangrong Wang, Xiaolan Lu, Qin Du, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 17
Guangrong Wang, Xiaolan Lu, Qin Du, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 17
Dynamic liver function is an independent predictor of recurrence-free survival after curative liver resection for HCC - A retrospective cohort study
Elisabeth Blüthner, Jan Bednarsch, Maciej Malinowski, et al.
International Journal of Surgery (2019) Vol. 71, pp. 56-65
Open Access | Times Cited: 16
Elisabeth Blüthner, Jan Bednarsch, Maciej Malinowski, et al.
International Journal of Surgery (2019) Vol. 71, pp. 56-65
Open Access | Times Cited: 16
Expression, clinicopathologic and prognostic significance of plasminogen activator inhibitor 1 in hepatocellular carcinoma
Ye Jin, Zhiyong Liang, Weixun Zhou, et al.
Cancer Biomarkers (2019) Vol. 27, Iss. 3, pp. 285-293
Closed Access | Times Cited: 15
Ye Jin, Zhiyong Liang, Weixun Zhou, et al.
Cancer Biomarkers (2019) Vol. 27, Iss. 3, pp. 285-293
Closed Access | Times Cited: 15
Non-Cirrhotic Liver is Associated with Poor Prognosis of Hepatocellular Carcinoma: A Literature Review
Yan Liu, Li Hao, Nan Ye, et al.
Medical Science Monitor (2019) Vol. 25, pp. 6615-6623
Open Access | Times Cited: 14
Yan Liu, Li Hao, Nan Ye, et al.
Medical Science Monitor (2019) Vol. 25, pp. 6615-6623
Open Access | Times Cited: 14
Prognosis After Resection of Hepatitis B Virus-Related Hepatocellular Carcinoma Originating from Non-cirrhotic Liver
Yanming Zhou, Xiaofeng Zhang, Bin Li, et al.
Annals of Surgical Oncology (2014) Vol. 21, Iss. 7, pp. 2406-2412
Closed Access | Times Cited: 12
Yanming Zhou, Xiaofeng Zhang, Bin Li, et al.
Annals of Surgical Oncology (2014) Vol. 21, Iss. 7, pp. 2406-2412
Closed Access | Times Cited: 12
The preoperative globulin‐to‐albumin ratio, a novel inflammation‐based prognostic system, predicts survival after potentially curative liver resection for patients with hepatocellular carcinoma
Takayuki Shimizu, Mitsuru Ishizuka, Takashi Suzuki, et al.
Journal of Surgical Oncology (2017) Vol. 116, Iss. 8, pp. 1166-1175
Closed Access | Times Cited: 12
Takayuki Shimizu, Mitsuru Ishizuka, Takashi Suzuki, et al.
Journal of Surgical Oncology (2017) Vol. 116, Iss. 8, pp. 1166-1175
Closed Access | Times Cited: 12
S3-Leitlinie: Diagnostik und Therapie des hepatozellulären Karzinoms
Sabrina Voesch, Michael Bitzer, Albert Jörg, et al.
Zeitschrift für Gastroenterologie (2022) Vol. 60, Iss. 01, pp. e56-e130
Open Access | Times Cited: 7
Sabrina Voesch, Michael Bitzer, Albert Jörg, et al.
Zeitschrift für Gastroenterologie (2022) Vol. 60, Iss. 01, pp. e56-e130
Open Access | Times Cited: 7
The prognostic role of an optimal machine learning model based on clinical available indicators in HCC patients
Xiaoying Lou, Shaohui Ma, Mingyuan Ma, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 1
Xiaoying Lou, Shaohui Ma, Mingyuan Ma, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 1
Outcomes Following Resection of Hepatocellular Carcinoma in the Absence of Cirrhosis
Richard H. Lewis, Evan S. Glazer, David M. Bittenbinder, et al.
Journal of Gastrointestinal Cancer (2018) Vol. 50, Iss. 4, pp. 808-815
Closed Access | Times Cited: 10
Richard H. Lewis, Evan S. Glazer, David M. Bittenbinder, et al.
Journal of Gastrointestinal Cancer (2018) Vol. 50, Iss. 4, pp. 808-815
Closed Access | Times Cited: 10
Prognostic Nomogram for Hepatitis B Virus–related Hepatocellular Carcinoma With Adjuvant Transarterial Chemoembolization After Radical Resection
Jian Huang, Fuchen Liu, Li Li, et al.
American Journal of Clinical Oncology (2019) Vol. 43, Iss. 1, pp. 20-27
Closed Access | Times Cited: 9
Jian Huang, Fuchen Liu, Li Li, et al.
American Journal of Clinical Oncology (2019) Vol. 43, Iss. 1, pp. 20-27
Closed Access | Times Cited: 9
Tumor grade may be used to select patients with multifocal hepatocellular carcinoma for resection
Samantha M. Ruff, Luke D. Rothermel, Laurence P. Diggs, et al.
HPB (2019) Vol. 22, Iss. 7, pp. 1004-1010
Open Access | Times Cited: 9
Samantha M. Ruff, Luke D. Rothermel, Laurence P. Diggs, et al.
HPB (2019) Vol. 22, Iss. 7, pp. 1004-1010
Open Access | Times Cited: 9
A prognosis model for patients with hepatocellular carcinoma and portal vein tumor thrombus following hepatic resection
Cheng-Zuo Xiao, Wei Wei, Zhixing Guo, et al.
Oncology Letters (2015) Vol. 10, Iss. 5, pp. 2787-2794
Open Access | Times Cited: 8
Cheng-Zuo Xiao, Wei Wei, Zhixing Guo, et al.
Oncology Letters (2015) Vol. 10, Iss. 5, pp. 2787-2794
Open Access | Times Cited: 8
Expert consensus on the role of hematological markers in the early clinical screening of hepatocellular carcinoma
Liver Research (2022) Vol. 6, Iss. 2, pp. 66-71
Open Access | Times Cited: 6
Liver Research (2022) Vol. 6, Iss. 2, pp. 66-71
Open Access | Times Cited: 6
Factors affecting overall survival and disease-free survival after surgery for hepatocellular carcinoma: a nomogram-based prognostic model—a Western European multicenter study
Yoshio Masuda, Mark Hao Xuan Yeo, Fernando Burdı́o, et al.
Updates in Surgery (2023) Vol. 76, Iss. 1, pp. 57-69
Closed Access | Times Cited: 3
Yoshio Masuda, Mark Hao Xuan Yeo, Fernando Burdı́o, et al.
Updates in Surgery (2023) Vol. 76, Iss. 1, pp. 57-69
Closed Access | Times Cited: 3
Large hepatocellular carcinoma: Does fibrosis really impact prognosis after resection?
Nicolas Golse, A. El Bouyousfi, F. Marques, et al.
Journal of Visceral Surgery (2018) Vol. 155, Iss. 4, pp. 265-273
Open Access | Times Cited: 6
Nicolas Golse, A. El Bouyousfi, F. Marques, et al.
Journal of Visceral Surgery (2018) Vol. 155, Iss. 4, pp. 265-273
Open Access | Times Cited: 6
Outcome after Resection for Hepatocellular Carcinoma in Noncirrhotic Liver—A Single Centre Study
Lea Penzkofer, Jens Mittler, Stefan Heinrich, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 19, pp. 5802-5802
Open Access | Times Cited: 4
Lea Penzkofer, Jens Mittler, Stefan Heinrich, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 19, pp. 5802-5802
Open Access | Times Cited: 4
S3-Leitlinie Diagnostik und Therapie biliärer Karzinome – Langversion
Michael Bitzer, Sabrina Groß, Jörg Albert, et al.
Zeitschrift für Gastroenterologie (2023) Vol. 61, Iss. 04, pp. e92-e156
Open Access | Times Cited: 2
Michael Bitzer, Sabrina Groß, Jörg Albert, et al.
Zeitschrift für Gastroenterologie (2023) Vol. 61, Iss. 04, pp. e92-e156
Open Access | Times Cited: 2
Characteristics and survival of hepatocellular carcinoma in non-cirrhotic liver.
Marta Romero-Gutiérrez, María Abanades Tercero, Juan Ruiz Martín, et al.
Revista Española de Enfermedades Digestivas (2019) Vol. 111
Open Access | Times Cited: 5
Marta Romero-Gutiérrez, María Abanades Tercero, Juan Ruiz Martín, et al.
Revista Española de Enfermedades Digestivas (2019) Vol. 111
Open Access | Times Cited: 5
Construction of a predictive nomogram and bioinformatic investigation of the potential mechanism of postoperative early recurrence of hepatocellular carcinoma meeting the Milan criteria
Shuqi Zhang, Liangliang Xu, Fuzhen Dai, et al.
Annals of Translational Medicine (2022) Vol. 10, Iss. 16, pp. 866-866
Open Access | Times Cited: 3
Shuqi Zhang, Liangliang Xu, Fuzhen Dai, et al.
Annals of Translational Medicine (2022) Vol. 10, Iss. 16, pp. 866-866
Open Access | Times Cited: 3
Status of hepatocellular cancer in Europe.
Alexa Childs, James O’Beirne, Tim Meyer
PubMed (2013) Vol. 2, Iss. 4, pp. 44-44
Closed Access | Times Cited: 2
Alexa Childs, James O’Beirne, Tim Meyer
PubMed (2013) Vol. 2, Iss. 4, pp. 44-44
Closed Access | Times Cited: 2
Laparoscopic versus open liver resection for huge hepatocellular carcinoma (≥ than 10 cm): a retrospective analysis from a high-volume referral center
Gianluca Cassese, Ho‐Seong Han, Boram Lee, et al.
Surgical Endoscopy (2024) Vol. 38, Iss. 11, pp. 6324-6331
Open Access
Gianluca Cassese, Ho‐Seong Han, Boram Lee, et al.
Surgical Endoscopy (2024) Vol. 38, Iss. 11, pp. 6324-6331
Open Access
Operative Therapie des hepatozellulären Karzinoms
Stefan Farkas, Hans J. Schlitt
Der Radiologe (2014) Vol. 54, Iss. 7, pp. 673-678
Closed Access | Times Cited: 1
Stefan Farkas, Hans J. Schlitt
Der Radiologe (2014) Vol. 54, Iss. 7, pp. 673-678
Closed Access | Times Cited: 1
